Target intelligence / Profile preview

T-cell receptor recognizing Battey antigen-derived peptide–MHC class II complexes

Molecular classification
Receptor, T-cell receptor
01

Overview

The T-cell receptor (TCR) recognizing Battey antigen-derived peptide–MHC class II complexes is a specialized immune receptor found on the surface of CD4+ T lymphocytes (Janeway et al., 2001). It specifically binds to peptides derived from Mycobacterium intracellulare (historically known as the Battey bacillus) when they are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (Wolinsky, 1979). This interaction is a critical step in the cellular immune response against nontuberculous mycobacterial (NTM) infections, leading to T-cell proliferation and the secretion of pro-inflammatory cytokines like IFN-gamma and TNF-alpha (Griffith et al., 2007). While not a traditional target for small-molecule drugs, these TCRs are significant in the development of diagnostic assays, such as the PPD-B skin test, and are studied for their cross-reactivity with Mycobacterium tuberculosis antigens (Edwards et al., 1969). Understanding this TCR specificity is vital for differentiating between various mycobacterial infections and for designing targeted immunotherapies or vaccines for NTM lung disease. The receptor's role in orchestrating the delayed-type hypersensitivity response makes it a key focus in mycobacterial immunology research.

Other names
Battey-specific T-cell receptorMycobacterium intracellulare-reactive TCRPPD-B-reactive T-cell receptorTCR recognizing M. intracellulare antigens
02

Mechanism of action

The TCR recognizes and binds to the specific peptide-MHC II complex, initiating intracellular signaling via the CD3 complex, leading to T-cell activation, cytokine secretion, and orchestration of the cell-mediated immune response against Mycobacterium intracellulare.

03

Biological functions

Immune responseAntigen recognitionT-cell activationCell-mediated immunity
04

Disease associations

InfectionNontuberculous mycobacterial infectionMycobacterium avium complex (MAC) infectionTuberculosis (cross-reactivity)
05

Safety considerations

Cross-reactivity with Mycobacterium tuberculosis antigensPotential for hypersensitivity reactionsRisk of immune-mediated tissue damage
06

Interacting drugs

Battey antigen (PPD-B)

1 more in the full profile.

07

Biomarkers

Interferon-gamma (IFN-γ) releaseT-cell proliferation indexSpecific TCR CDR3 sequences

Beyond the preview

Go deeper on T-cell receptor recognizing Battey antigen-derived peptide–MHC class II complexes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing Battey antigen-derived peptide–MHC class II complexes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call